Cart
sales@molnova.com
246-Tribromophenyl caproate
CAS No. 16732-09-5
246-Tribromophenyl caproate( —— )
Catalog No. M20929 CAS No. 16732-09-5
246-Tribromophenyl caproate is a potent antifungal agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 28 | In Stock |
|
Biological Information
-
Product Name246-Tribromophenyl caproate
-
NoteResearch use only, not for human use.
-
Brief Description246-Tribromophenyl caproate is a potent antifungal agent.
-
Description246-Tribromophenyl caproate is a potent antifungal agent.
-
In Vitro——
-
In Vivo2,4,6-Tribromophenyl caproate (2,4,6-tribromophenyl caproic acid ester) contains at least one selected from Sharon skin or a salt thereof transdermal absorption patch according to any one of the first term through the fifth term.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntifungal
-
RecptorAntifungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16732-09-5
-
Formula Weight428.94
-
Molecular FormulaC12H13Br3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (116.57 mM)
-
SMILESCCCCCC(=O)Oc1c(Br)cc(Br)cc1Br
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Chlorobutanol hemihy...
Chlorobutanol hemihydrate (Chlorbutol hemihydrate) is an orally toxic preservative with antimicrobial activity that inhibits Gram-positive and Gram-negative bacteria and fungi, inhibits the aggregation and release of human platelets in vitro, and is commonly used in cosmetics.
-
Fluazinam
Fluazinam is a pyridinamine fungicide with a broad spectrum of antifungal activity and had a strong inhibition effect on mycelial growth of S. sclerotiorum populations.?
-
APX2039
APX2039 is an orally active fungal Gwt1 enzyme inhibitor and a prodrug of the novel Gwt2096 inhibitor APX1.APX2039 exhibits potent anti-Kryptococcal activity against C. neoformans and C. gattii.
